Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INNV	INNOVAGE HOLDING CORP	$752.79M	-12.30%	-5.70%	-6.74%	-9.00%	1.12	1.07	18.00%	-3.60%	-2.86%
RPTX	REPARE THERAPEUTICS INC	$78.06M	-78.10%	-67.10%	-101.29%	-151.70%	0.15	7.42	100.00%	-11,919.30%	-11,809.23%
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	$47.80M	N/A	-79.70%	-202.70%	-112.90%	-2.84	1.52	94.70%	-260.80%	-246.42%
ADIL	ADIAL PHARMACEUTICALS INC	$8.08M	-191.30%	-153.60%	-151.14%	-8,040.80%	0.22	5.02	N/A	N/A	N/A
PIII	P3 HEALTH PARTNERS INC	$62.17M	-192.00%	-18.60%	-48.64%	81.00%	14.49	0.31	-8.00%	-10.00%	-7.54%
SRXH	SRX HEALTH SOLUTIONS INC	$7.98M	N/A	-78.20%	41.92%	-386.40%	-1.74	0.33	34.80%	-43.30%	-45.29%
IGC	IGC PHARMA INC	$35.69M	-97.40%	-70.20%	-101.99%	-164.10%	0.31	1.25	46.00%	-477.90%	-477.92%
PHAR	PHARMING GROUP NV	$993.93M	-3.60%	-2.00%	1.06%	1.30%	0.86	2.80	89.30%	-2.40%	1.12%
VANI	VIVANI MEDICAL INC	$80.28M	-194.70%	-68.60%	-115.09%	-76.80%	4.89	1.30	N/A	N/A	N/A
INCR	INTERCURE LTD	$76.88M	-15.90%	-9.50%	-6.43%	-8.00%	0.74	1.85	11.40%	-29.20%	-14.54%
IPHA	INNATE PHARMA SA	$172.14M	-271.40%	-37.70%	-65.09%	-71.60%	17.07	2.21	100.00%	-364.40%	-327.14%
SMLR	SEMLER SCIENTIFIC INC	$389.81M	17.20%	12.90%	9.62%	15.40%	0.36	0.60	90.80%	86.20%	108.74%
INDP	INDAPTUS THERAPEUTICS INC	$4.46M	-612.60%	-243.80%	1,013.62%	1,268.40%	-5.09	0.75	N/A	N/A	N/A
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$111.62M	-2,898.10%	-117.30%	-144.31%	-1,076.10%	45.01	4.04	54.50%	-1,489.70%	-1,487.01%
RANI	RANI THERAPEUTICS HOLDINGS INC	$26.99M	-2,437.00%	-80.50%	-628.76%	-58.10%	-9.65	0.88	100.00%	-2,483.20%	-2,093.25%
SENS	SENSEONICS HOLDINGS INC	$341.35M	-283.70%	-62.80%	-45.27%	-69.00%	0.59	9.58	17.80%	-267.90%	-240.85%
HBIO	HARVARD BIOSCIENCE INC	$18.79M	-144.20%	-55.00%	-215.53%	-104.70%	4.09	0.82	56.90%	-64.70%	-60.45%
VIVS	VIVOSIM LABS INC	$7.70M	-33.00%	-21.40%	-20.06%	-143.80%	0.26	4.52	97.90%	-1,399.30%	-1,389.44%
PCSA	PROCESSA PHARMACEUTICALS INC	$22.20M	-342.40%	-243.50%	-210.93%	-3,727.00%	0.34	3.45	N/A	N/A	N/A
IRIX	IRIDEX CORP	$17.76M	-187.30%	-17.40%	-30.22%	-39.50%	4.21	1.96	39.50%	-11.00%	-10.86%
GNTA	GENENTA SCIENCE SPA	$66.44M	-60.10%	-42.90%	-43.58%	-52.50%	0.78	13.20	N/A	N/A	N/A
NEPH	NEPHROS INC	$56.61M	9.40%	7.20%	7.95%	12.80%	0.27	5.92	62.40%	5.20%	5.26%
GNFT	GENFIT SA	$212.51M	-51.70%	-18.80%	-13.83%	-17.70%	3.13	3.74	100.00%	-85.40%	-53.34%
VNRX	VOLITIONRX LTD	$48.74M	N/A	-237.40%	4,275.56%	8,595.30%	-1.31	0.35	100.00%	-1,767.90%	-1,737.41%
NERV	MINERVA NEUROSCIENCES INC	$17.69M	-41.40%	31.40%	40.26%	19.40%	-1.95	6.15	N/A	N/A	N/A
IXHL	INCANNEX HEALTHCARE INC	$141.86M	-661.50%	-294.00%	-346.00%	-1,347.30%	0.53	2.86	100.00%	-54,517.40%	-54,165.12%
SBFM	SUNSHINE BIOPHARMA INC	$7.11M	-26.00%	-20.70%	-24.48%	-50.70%	0.25	5.00	33.30%	-17.40%	-17.78%
GELS	GELTEQ LTD	$12.65M	N/A	N/A	N/A	N/A	0.34	0.79	N/A	N/A	N/A
SCYX	SCYNEXIS INC	$34.04M	-37.40%	-24.50%	-38.71%	-34.90%	0.37	5.20	100.00%	-599.00%	-592.14%
TELA	TELA BIO INC	$59.42M	-329.50%	-57.30%	-73.83%	-63.50%	6.35	3.19	67.30%	-54.10%	-47.52%
TXMD	THERAPEUTICSMD INC	$12.15M	-1.70%	-1.20%	-1.55%	-1.80%	0.41	2.89	100.00%	-17.90%	-20.44%
MTSR	METSERA INC	$5.56B	N/A	N/A	N/A	N/A	0.42	5.26	N/A	N/A	N/A
CCM	CONCORD MEDICAL SERVICES HOLDINGS LTD	$25.52M	N/A	-0.10%	6.46%	3.90%	-2.24	0.42	144.20%	-1.10%	47.29%
PLUR	PLURI INC	$36.53M	N/A	-63.40%	-338.46%	-45.60%	-5.78	0.68	49.00%	-1,690.30%	-1,609.96%
POAI	PREDICTIVE ONCOLOGY INC	$9.78M	N/A	-179.60%	2,384.36%	-598.90%	-3.08	0.32	48.50%	-913.60%	-913.57%
MOLN	MOLECULAR PARTNERS AG	$141.72M	-50.30%	-44.80%	-54.02%	-95.80%	0.17	9.35	100.00%	-9,515.90%	-8,832.90%
VSEE	VSEE HEALTH INC	$10.46M	-408.80%	-184.00%	-6,020.71%	1,169.30%	-1,082.38	0.16	68.90%	-553.70%	-567.43%
IMRN	IMMURON LTD	$12.17M	-50.30%	-40.70%	-63.80%	-160.50%	0.26	5.09	71.00%	-60.00%	-59.88%
MNOV	MEDICINOVA INC	$60.82M	-23.10%	-21.80%	-25.03%	-318.90%	0.06	13.26	13.60%	-8,775.80%	-8,771.68%
ATHE	ALTERITY THERAPEUTICS LTD	$85.07M	-43.20%	-37.20%	-28.43%	-222.50%	0.09	12.98	100.00%	-159.00%	-158.08%
MLSS	MILESTONE SCIENTIFIC INC	$42.34M	-133.80%	-73.20%	-162.83%	-225.70%	1.41	2.03	72.80%	-76.80%	-76.78%
JUNS	JUPITER NEUROSCIENCES INC	$50.51M	-835.30%	-155.10%	-429.83%	975.20%	1.96	1.07	N/A	N/A	N/A
EXOZ	EXOZYMES INC	$108.95M	-134.40%	-81.60%	-94.44%	-255.30%	0.34	6.19	N/A	N/A	N/A
ETNB	89BIO INC	$2.16B	-81.40%	-70.20%	-58.76%	-105.30%	0.13	18.03	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$9.37M	-77.60%	-63.10%	-99.12%	-137.10%	0.15	7.60	100.00%	-8,097.70%	-8,096.85%
SNSE	SENSEI BIOTHERAPEUTICS INC	$14.87M	-74.80%	-63.60%	-95.89%	-96.30%	0.16	7.64	N/A	N/A	N/A
SSKN	STRATA SKIN SCIENCES INC	$6.42M	-266.90%	-32.70%	-57.91%	-46.40%	98.75	0.98	57.90%	-35.10%	-29.47%
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$12.76M	5.90%	5.00%	7.91%	8.70%	0.16	5.71	34.30%	10.40%	14.57%
ERNA	ERNEXA THERAPEUTICS INC	$9.59M	N/A	-682.30%	-780.58%	-703.90%	0.71	1.81	112.30%	-8,959.00%	-7,890.57%
PRLD	PRELUDE THERAPEUTICS INC	$70.75M	-106.50%	-79.10%	-132.24%	-98.20%	0.52	3.68	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$122.72M	-95.10%	-82.80%	-50.44%	7,950.30%	0.12	13.07	4.00%	-4,525.10%	-4,518.83%
FBLG	FIBROBIOLOGICS INC	$18.35M	-609.20%	-101.20%	-448.93%	-1,214.30%	15.17	0.93	N/A	N/A	N/A
WHWK	WHITEHAWK THERAPEUTICS INC	$96.10M	26.20%	22.50%	12.50%	111.70%	0.06	18.95	88.70%	99.40%	99.77%
PINC	PREMIER INC	$2.31B	1.20%	0.60%	2.87%	3.20%	1.02	0.64	73.40%	2.00%	6.20%
TRML	TOURMALINE BIO INC	$1.23B	-30.50%	-29.60%	-34.13%	-34.40%	0.04	24.68	N/A	N/A	N/A
POCI	PRECISION OPTICS CORPORATION INC	$32.71M	-51.30%	-31.20%	-40.70%	-112.70%	0.61	1.64	17.80%	-30.30%	-29.08%
PULM	PULMATRIX INC	$17.90M	-97.20%	-89.00%	-141.51%	2,758.30%	0.10	11.21	100.00%	-2,149.10%	-2,149.05%
ESLA	ESTRELLA IMMUNOPHARMA INC	$55.60M	N/A	-392.70%	198.13%	420.40%	-1.49	0.16	N/A	N/A	N/A
TRIB	TRINITY BIOTECH PLC	$19.40M	N/A	-33.00%	-30.53%	-19.20%	-3.94	1.28	34.80%	-51.60%	-35.31%
WORX	SCWORX CORP	$2.17M	-60.00%	-45.00%	-22.94%	111.40%	0.22	0.68	21.40%	-105.80%	-44.11%
LFWD	LIFEWARD LTD	$11.78M	-137.90%	-90.30%	-181.00%	-408.10%	0.77	2.00	35.60%	-121.80%	-121.63%
WOK	WORK MEDICAL TECHNOLOGY GROUP LTD	$1.14M	-32.00%	-11.00%	-21.30%	-13.70%	1.47	1.14	26.90%	-34.50%	-31.20%
ELUT	ELUTIA INC	$38.37M	N/A	-54.60%	426.69%	-139.50%	-1.81	0.59	44.70%	-90.90%	-73.85%
BNR	BURNING ROCK BIOTECH LTD	$92.50M	-23.70%	-15.80%	-22.57%	-66.90%	0.46	3.22	72.10%	-26.10%	-25.03%
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-46.10%	269.50%	86.10%	-5.17	0.56	64.50%	-97.50%	-110.40%
EDSA	EDESA BIOTECH INC	$17.82M	-103.10%	-78.70%	-37.56%	570.50%	0.06	15.73	N/A	N/A	N/A
LNSR	LENSAR INC	$141.15M	-777.70%	-86.20%	-123.60%	-176.80%	-3.67	1.81	47.90%	-99.20%	-99.16%
RLYB	RALLYBIO CORP	$22.06M	-71.70%	-65.10%	-90.62%	-98.10%	0.11	9.98	100.00%	-5,473.30%	-5,473.32%
EDAP	EDAP TMS SA	$77.76M	-57.60%	-27.30%	-61.10%	-78.70%	1.46	1.51	42.50%	-33.30%	-33.19%
RVP	RETRACTABLE TECHNOLOGIES INC	$28.98M	-11.10%	-5.80%	-6.07%	-5.90%	0.92	7.01	-6.90%	-23.50%	-21.95%
CSBR	CHAMPIONS ONCOLOGY INC	$89.76M	87.90%	9.90%	36.58%	36.90%	7.70	0.93	48.50%	5.20%	5.05%
LVTX	LAVA THERAPEUTICS NV	$40.51M	-106.60%	-38.40%	-49.09%	-82.60%	2.04	10.78	100.00%	-568.80%	-540.42%
LYRA	LYRA THERAPEUTICS INC	$13.02M	-412.00%	-61.20%	-93.74%	-75.60%	31.41	2.78	100.00%	-5,043.60%	-5,041.17%
TLPH	TALPHERA INC	$24.01M	-151.40%	-63.90%	-81.42%	-82.70%	1.49	2.93	100.00%	-41,870.40%	-41,870.37%
CYCN	CYCLERION THERAPEUTICS INC	$7.68M	-22.60%	-20.70%	-22.71%	-36.00%	0.09	5.03	100.00%	-89.50%	-89.51%
XBIT	XBIOTECH INC	$78.05M	-15.60%	-14.60%	-15.81%	-130.50%	0.03	40.16	N/A	N/A	N/A
RADX	RADIOPHARM THERANOSTICS LTD	$50.37M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
ZCMD	ZHONGCHAO INC	$18.25M	-9.00%	-6.70%	-4.34%	-6.80%	0.13	8.15	52.50%	-12.90%	-7.92%
ZIMV	ZIMVIE INC	$534.97M	-4.90%	-2.60%	1.22%	1.80%	0.84	2.37	65.30%	-4.40%	1.79%
CTSO	CYTOSORBENTS CORP	$58.23M	-114.40%	-31.80%	-37.84%	-28.70%	2.49	2.61	71.70%	-45.90%	-44.98%
MBRX	MOLECULIN BIOTECH INC	$14.17M	-1,676.40%	-128.10%	-194.08%	707.20%	-4.01	1.15	N/A	N/A	N/A
TRAW	TRAWS PHARMA INC	$20.49M	-1,812.50%	512.70%	1,063.00%	-1,416.90%	0.89	2.09	100.00%	3,028.20%	3,028.25%
AEON	AEON BIOPHARMA INC	$1.25M	N/A	-20.10%	-64.59%	-21.60%	-1.74	1.12	N/A	N/A	N/A
DYAI	DYADIC INTERNATIONAL INC	$38.72M	-355.30%	-60.70%	-113.79%	-79.20%	-16.36	2.02	59.90%	-134.80%	-123.19%
SEER	SEER INC	$124.51M	-25.90%	-23.20%	-26.45%	-25.40%	0.12	19.15	49.90%	-506.20%	-504.64%
ADXN	ADDEX THERAPEUTICS LTD	$6.70M	-66.80%	-59.30%	-82.04%	-95.50%	0.18	2.31	100.00%	-3,616.40%	-3,607.23%
ANEB	ANEBULO PHARMACEUTICALS INC	$95.32M	-80.80%	-76.30%	-69.50%	-4,829.60%	0.04	24.53	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$8.28M	-54.50%	-47.30%	-69.28%	3,722.20%	0.20	5.93	100.00%	-126.00%	-126.03%
CV	CAPSOVISION INC	$218.43M	N/A	N/A	N/A	N/A	-0.04	1.85	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$61.45M	-78.00%	-31.60%	-35.44%	83.00%	0.99	0.19	N/A	N/A	N/A
CUE	CUE BIOPHARMA INC	$62.63M	-230.10%	-111.20%	-178.91%	-2,975.80%	1.24	1.60	100.00%	-469.30%	-463.15%
ZTEK	ZENTEK LTD	$77.07M	-55.70%	-45.90%	-55.76%	-55.90%	0.32	1.62	24.60%	-956.80%	-945.83%
NBTX	NANOBIOTIX SA	$1.46B	N/A	-78.30%	217.34%	-442.80%	-1.66	0.63	100.00%	-508.40%	-382.20%
IBO	IMPACT BIOMEDICAL INC	$7.43M	-528.70%	-145.10%	907.95%	-2,020.30%	-2.56	0.06	-57.10%	-549,628.60%	-533,357.14%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$4.07M	-772.80%	-347.10%	-310.34%	9,001.30%	0.53	3.07	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$14.75M	N/A	-628.00%	65.76%	84.40%	-1.17	0.15	100.00%	-12,282.00%	-6,089.62%
LPTX	LEAP THERAPEUTICS INC	$24.99M	-237.60%	-155.40%	-1,138.48%	485.50%	2.51	1.34	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$24.87M	-102.60%	-50.60%	2,678.82%	-23,768.00%	-25.86	0.97	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	625	+0.15%	+0.57%	+11.45%	-26.73%	-107.73x	4.94x	-101.72%	-7.75%	-15.20%	+65.40%	Strong Buy
Diagnostics & Research	56	+1.56%	-1.66%	+5.23%	-6.54%	22.72x	4.01x	-3.00%	+7.08%	+15.20%	+7.02%	Buy
Drug Manufacturers - General	20	-0.55%	-1.85%	+6.16%	-5.12%	39.78x	6.38x	+60.40%	+10.49%	+18.04%	+9.06%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.55%	-2.66%	-4.56%	-24.09%	-47.05x	2.20x	+10.76%	+3.94%	+9.26%	+41.19%	Strong Buy
Healthcare Plans	10	-0.56%	-2.29%	+5.05%	-27.64%	15.46x	2.12x	+15.83%	+4.97%	+11.53%	+12.35%	Buy
Health Information Services	55	+1.04%	-2.60%	-0.49%	-49.92%	72.89x	4.53x	-42.47%	-1.17%	+2.71%	+26.01%	Strong Buy
Medical Care Facilities	48	+0.25%	-2.55%	+1.06%	-30.33%	16.42x	4.93x	-183.78%	+6.84%	+15.24%	+17.93%	Buy
Medical Devices	140	+0.79%	-1.96%	-1.95%	-27.57%	29.39x	3.88x	+13.63%	+8.47%	+10.00%	+30.65%	Strong Buy
Medical Distribution	11	+0.18%	+2.76%	+7.68%	+39.39%	29.27x	315.66x	-9.33%	+3.10%	+19.06%	+10.73%	Buy
Medical Instruments & Supplies	56	+0.20%	-3.36%	-1.30%	-61.51%	32.16x	3.31x	+10.51%	+8.44%	+11.14%	+26.71%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #1 top healthcare stock out of 1098 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock return 1.99% over the past year, overperforming other healthcare stocks by 30 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 38.58% from Embecta's current stock price of $13.35.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1098 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 37, which is 12 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 12.59% over the past year, overperforming other healthcare stocks by 41 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $14.00, an upside of 43.59% from Amneal Pharmaceuticals's current stock price of $9.75.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1098 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: C, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 30, which is 5 points higher than the healthcare sector average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 74.31% over the past year, overperforming other healthcare stocks by 103 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $8.08, a downside of -8.36% from Aveanna Healthcare Holdings's current stock price of $8.82.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.94%, which is 12 percentage points higher than the healthcare sector average of 2.1%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 8.65%, which is 7 percentage points higher than the healthcare sector average of 2.1%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.97%, which is 6 percentage points higher than the healthcare sector average of 2.1%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 150.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.44% in the last day, and down -1.09% over the last week. Compugen was the among the top gainers in the healthcare sector, gaining 21.08% yesterday.

Compugen shares are trading higher after the company published pooled data showing COM701 activity in platinum-resistant ovarian cancer ahead of its ESMO presentation.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -25.7% in the past year. It has overperformed other stocks in the healthcare sector by 3 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has gained 1.99% in the past year. It has overperformed other stocks in the healthcare sector by 30 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 29, which is 13 points higher than the healthcare sector average of 16. It passed 2 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -5.48% in the past year. It has overperformed other stocks in the healthcare sector by 23 percentage points.

Are healthcare stocks a good buy now?

52.96% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 34.24% over the next year.

4.9% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.49% of healthcare stocks are rated B (Buy), 47.61% are rated C (Hold), 24.5% are rated D (Sell), and 10.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 8.36x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.